Skip to main content
TipRanks
Go Ultimate75% OFF

IMPACT Therapeutics, Inc. Class H (7630) Stock Statistics & Valuation Metrics

Total Valuation

IMPACT Therapeutics, Inc. Class H has a market cap or net worth of HKD 2.46B. The enterprise value is HKD 7.65B.

Market Cap
HKD 2.46B
Enterprise Value
HKD 7.65B

Share Statistics

IMPACT Therapeutics, Inc. Class H has 282,461,520 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
282,461,520
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

IMPACT Therapeutics, Inc. Class H’s return on equity (ROE) is 0.30 and return on invested capital (ROIC) is -95.95%.

Return on Equity (ROE)
0.30
Return on Assets (ROA)
-0.86
Return on Invested Capital (ROIC)
-95.95%
Return on Capital Employed (ROCE)
-0.97
Revenue Per Employee
60.56K
Profits Per Employee
-468.49K
Employee Count
88
Asset Turnover
0.11
Inventory Turnover
0.22

Valuation Ratios

The current PE Ratio of IMPACT Therapeutics, Inc. Class H is -7.72. IMPACT Therapeutics, Inc. Class H’s PEG ratio is -0.08.

PE Ratio
-7.72
PS Ratio
16.43
PB Ratio
2.52
Price to FCF
-19.89
Price to Operating Cash Flow
-20.44
PEG Ratio
-0.08

Income Statement

In the last 12 months, IMPACT Therapeutics, Inc. Class H had revenue of 5.33M and earned -41.23M in profits. Earnings per share was -0.15.

Revenue
5.33M
Gross Profit
4.49M
Operating Income
-32.04M
Pretax Income
-41.23M
Net Income
-41.23M
EBITDA
-31.42M
Earnings Per Share (EPS)
-0.15

Cash Flow

In the last 12 months, operating cash flow was -14.10M and capital expenditures -64,095, giving a free cash flow of -14.16M billion.

Operating Cash Flow
-14.10M
Free Cash Flow
-14.16M
Free Cash Flow per Share
-0.05

Dividends & Yields

IMPACT Therapeutics, Inc. Class H pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-4.96%
Earnings Yield
-12.58%

Stock Price Statistics

Beta
-0.36
52-Week Price Change
-79.18%
50-Day Moving Average
11.66
200-Day Moving Average
19.55
Relative Strength Index (RSI)
40.82
Average Volume (3m)
5.53M

Important Dates

IMPACT Therapeutics, Inc. Class H upcoming earnings date is ―, Before Open (Confirmed).

Last Earnings Date
Aug 31, 2026
Next Earnings Date
―
Ex-Dividend Date
―

Financial Position

IMPACT Therapeutics, Inc. Class H as a current ratio of 3.08, with Debt / Equity ratio of -89.98%

Current Ratio
3.08
Quick Ratio
2.82
Debt to Market Cap
0.08
Net Debt to EBITDA
-2.75
Interest Coverage Ratio
-3.35

Taxes

In the past 12 months, IMPACT Therapeutics, Inc. Class H has paid ― in taxes.

Income Tax
―
Effective Tax Rate
-0.00

Enterprise Valuation

IMPACT Therapeutics, Inc. Class H EV to EBITDA ratio is -5.67, with an EV/FCF ratio of -11.66.

EV to Sales
9.63
EV to EBITDA
-5.67
EV to Free Cash Flow
-11.66
EV to Operating Cash Flow
-11.71

Balance Sheet

IMPACT Therapeutics, Inc. Class H has HKD 156.99M in cash and marketable securities with HKD 623.31K in debt, giving a net cash position of HKD 156.37M billion.

Cash & Marketable Securities
HKD 156.99M
Total Debt
HKD 623.31K
Net Cash
HKD 156.37M
Net Cash Per Share
HKD 0.55
Tangible Book Value Per Share
HKD 0.40

Margins

Gross margin is 87.17%, with operating margin of -173.71%, and net profit margin of -214.26%.

Gross Margin
87.17%
Operating Margin
-173.71%
Pretax Margin
-214.26%
Net Profit Margin
-214.26%
EBITDA Margin
-169.94%
EBIT Margin
-173.71%

Analyst Forecast

The average price target for IMPACT Therapeutics, Inc. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
394.93%
EPS Growth Forecast
15.73%

Scores

Smart Score
6
AI Score
42